Searching for markers to identify angiogenic endothelial cells: A proteomic approach

Clinical Hemorheology and Microcirculation

Volumn 55, Issue 2, 2013, Pages 255-269

  Bahramsoltani, Mahtab ^a   Harms, Tobias ^b   Drewes, Barbara ^b   Plendl, Johanna ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Angiogenic endothelial cells; In vitro model; Two dimensional gel electrophoresis

Indexed keywords

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS;

ANGIOGENIC ENDOTHELIAL CELLS; IN VITRO MODEL; TWO-DIMENSIONAL GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; MICROSCOPY, PHASE-CONTRAST; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEINS; PROTEOMICS; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84889652755     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-2012-1631     Document Type: Article

References (54)

1. R. Auerbach, R. Lewis, B. Shinners, L. Kubai and N. Akhtar, Angiogenesis assays: A critical overview, Clin Chem 49 (2003), 32-40.
2. M. Bahramsoltani, W. De Spiegelaere, P. Janczyk, B. Hiebl, P. Cornillie and J. Plendl, Quantitation of angiogenesis in vitro induced by VEGF-A and FGF-2 in two different human endothelial cultures-an all-in-one-assay, Clin Hemorheol Microcirc 46 (2010), 189-202.
3. M. Bahramsoltani and J. Plendl, Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis, APMIS 115 (2007), 30-46.
4. M. Bahramsoltani and J. Plendl, Ein neues in vitro Modell zur Quantifizierung der Angiogenese, ALTEX 21 (2004), 199-246.
5. M. Bahramsoltani, J. Plendl, P. Janczyk, P. Custodis and S. Kaessmeyer, Quantitation of angiogenesis and antiangiogenesis in vivo, ex vivo and in vitro -an overview, ALTEX 26 (2009), 95-107.
6. S. Banerjee and M. Bacanamwo, DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells, Exp Cell Res 316 (2010), 172-180.
7. M.U. Becher, G. Nickenig and N. Werner, Regeneration of the vascular compartment, Herz 35 (2010), 342-351.
8. N.S. Bhise, R.B. Shmueli, J.C. Sunshine, S.Y. Tzeng and J.J. Green, Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis, Expert Opin Drug Deliv 8 (2011), 485-504.
9. A.C. Browning, T. Gray and W.M. Amoaku, Isolation, culture, and characterisation of human macular inner choroidal microvascular endothelial cells, Br J Ophtalmol 89 (2005), 1343-1347.
10. Y. Cao, Therapeutic angiogenesis for ischemic disorders: What is missing for clinical benefit? Discov Med 9 (2010), 179-184.
11. P. Carmeliet and R.K. Jain, Molecular mechanisms and clinical applications of angiogenesis, Nature 473 (2011), 298-307.
12. T. Chan-Ling, J.E. Dahlstrom and M.E. Koina, J.R. McColm, R.A. Sterling, E.G. Bean, S. Adamson, S. Hughes and L.C. Baxter, Evidence of hematopoietic differentiation, vasculogenesis and angiogenesis in the formation of human choroidal blood vessels, Exp Eye Res 92, 2011 361-376.
13. M.W. Dewhirst, Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress, Radiat Res 172 (2009), 653-665.
14. M. Fontecave, M. Atta and E. Mulliez, S-adenosylmethionine: nothing goes to waste, Trends Biochem Sci 29 (2004), 243-249.
15. J. Fu, H. Gerhardt, J.M. McDaniel, B. Xia, X. Liu, L. Ivanciu, A. Ny, K. Hermans, R. Silasi-Mansat, S. McGee, E. Nye, T. Ju, M.I. Ramirez, P. Carmeliet, R.D. Cummings, F. Lupu and L. Xia, Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice, J Clin Invest 118 (2008), 3725-3737.
16. H. Gerhardt, M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, A. Abramsson, M. Jeltsch, C. Mitchell, K. Alitalo, D. Shima and C. Betsholtz, VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia, J Cell Biol 161 (2003), 1163-1177.
17. Y. Hata, M. Miura, S. Nakao, S. Kawahara, T. Kita and T. Ishibashi, Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor, Jpn J Ophtalmol 52 (2008), 16-23.
18. T. Hayashi, K. Deguchi, S. Nagotani, H. Zhang, Y. Sehara, A. Tsuchiya and K. Abe, Cerebral ischemia and angiogenesis, Curr Neurovasc Res 3 (2006), 119-129.
19. H. Inoue and P.A. Randazzo, Arf GAPs and their interacting proteins, Traffic 11 (2007), 1465-1475.
20. M.N. Jabbour, J.B. Elder, C.G. Smuelson, S. Khashabi, F.M. Hofman, S.L. Giannotta and C.Y. Liu, Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells, Neurosurgery 64 (2009), 139-146.
21. T.R. Jackson, F.D. Brown, Z. Nie, K. Miura, L. Foroni, J. Sun, V.W. Hsu, J.G. Donaldson and P.A. Randazzo, ACAPs are arf6 GTPase-activating proteins that function in the cell periphery, J Cell Biol 151 (2000), 627-638.
22. L. Jakobsson, C.A. Franco, K. Bentley, R.T. Collins, B. Ponsioen, I.M. Aspalter, I. Rosewell, M. Busse, G. Thurston, A. Medvinsky, S. Schulte-Merker and H. Gerhardt, Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting, Nat Cell Biol 12 (2010), 943-953.
23. H. Jin, B. Garmy-Susini, C.J. Avraamides, K. Stoletov, R.L. Klemke, and J.A. Varner, A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting, Blood 116 (2010), 5773-5783.
24. C.J. Kirkpatrick, V. Krump-Konvalinkova, R.E. Unger, F. Bittinger, M. Otto and K. Peters, Tissue response and biomaterial integration: The efficacy of in vitro methods, Biomol Eng 19 (2002), 211-217.
25. T. Kubota, T. Shiba, S. Sugioka, S. Furukawa, H. Sawaki, R. Kato, S. Wakatsuki and H. Narimatsu, Structural basis of carbohydrate transfer activity by human UDP-GalNAc: Polypeptide alpha-N-acetylgalactosaminyl transferase (pp-GalNAc-T10), J Mol Biol 359 (2006), 708-727.
26. K. Lehle, M. Hoenicka, V.R. Jacobs, F.X. Schmid and D.E. Birnbaum, Cryopreservation of human endothelial cells for vascular tissue engineering, Cryobiology 50 (2005), 154-161.
27. V. Limaye, P. Xia, C. Hahn, M. Smith, M.A. Vadas, S.M. Pitson and J.R. Gamble, Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells, Cell Mol Biol Lett 14 (2009), 424-441.
28. T. Liu, O.E. Guevara, R.R. Warburton, N.S. Hill, M. Gaestel and U.S. Kayyali, Regulation of vimentin intermediate filaments in endothelial cells by hypoxia, Am J Physiol Cell Physiol 299 (2010), C363-C373.
29. X. Liu, J. Shen, R. Zhan, X. Wang, X. Wang, Z. Zhang, X. Leng, Z. Yang and L. Qian, Proteomic analysis of homocysteine induced proliferation of cultured neonatal rat vascular smooth muscle cells, Biochim Biophys Acta 1794 (2009), 177-184.
30. X. Lu, S.J. Proctor and A.M. Dickinson, The effect of cryopreservation on umbilical cord blood endothelial progenitor cell differentiation, Cell Transplant 17 (2008), 1423-1428.
31. M.J. Lynch, G.S. Baillie and M.D. Houslay, cAMP-specific phosphodiesterase-4D5 (PDE4D5) provides a paradigm for understanding the unique non-redundant roles that PDE4isoforms play in shaping compartmentalizedc AMP cell signalling, Biochem Soc Trans 35 (2007), 938-941.
32. A. Mayer, S. Lee, F. Jung, G. Grütz, A. Lendlein and B. Hiebl, CD14 + CD163 + IL-10 + monocytes/macrophages: Proangiogenic and non pro-inflammatory isolation, enrichment and long-term secretion profile, Clin Hemorheol Microcirc 46 (2010), 217-223.
33. E. Nordhoff and H. Lehrach, Identification and characterization of DNA-binding proteins by mass spectrometry, Adv Biochem Eng Biotechnol 104 (2007), 111-195.
34. P. Nowak-Sliwinska, J.R. van Bejinum, M. von Berkel, H. Van den Bergh and A.W. Griffioen, Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane, Angiogenesis 13 (2010), 281-292.
35. M. Ohki, Y. Ohki, M. Ishihara, C. Nishida, Y. Tashiro, H. Akiyama, H. Komiyama, L.R. Lund, A. Nitta, K. Yamada, Z. Zhu, H. Ogawa, H. Yagita, K. Okumura, H. Nakauchi, Z. Werb, E. Heissig and K. Hattori, Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regeneration, Blood 115 (2010), 4302-4312.
36. A. Osio, L. Tan, S.N. Chen, R. Lombardi, S.F. Nagueh, S. Shete, R. Roberts, J.T. Willerson and A.J. Marian, Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy, Circ Res 100 (2007), 766-768.
37. B. Polchow, K. Kebbel, G. Schmiedeknecht, A. Reichardt, W. Henrich, R. Hetzer and C. Lueders, Cryopreservaton of human vascular umbilical cord cells under good manufacturing practice conditions for future cell banks, J Transl Med 10 (2012), 98.
38. J. Qiu, H.Q. Gao, R.H. Zhou, Y. Liang, X.H. Zhang, X.P. Wang, B.A. You and M. Cheng, Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells, Biol Pharm Bull 30 (2007), 247-253.
39. A. Ring, D.J. Tilkorn, O. Goertz, S. Langer, A. Schaffran, P. Awakowicz and J. Hauser, Surface modification by glow discharge gasplasma treatment improves vascularization of allogenic bone implants, J Orthop Res 29 (2011), 1237-1244.
40. M. Sahin, E. Sahin, S. Gümüslü, A. Erdoǧan and M. Gültekin, DNA methylation or histone modification status in metastasis and angiogenesis-related genes: A new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability, Cancer Metastasis Rev 29 (2010), 655-676.
41. A. Sharma, D.J. Bettis, J.W. Cowden and R.R. Mohan, Localization of Angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo, Mol Vis 16 (2010), 720-728.
42. C.D. Shrader, K.M. Bailey, G.W. Konat, E.V. Cilento and F.D. Reilly, Insulin enhances proliferation and viability of human umbilical vein endothelial cells, Arch Dermatol Res 301 (2009), 159-166.
43. H. Sievers, M. Bahramsoltani, S. Kaessmeyer and J. Plendl, In vitro angiogenic potency in human microvascular endothelial cells derived from myocardium, lung and skin, Clin Hemorheol Microcirc 49 (2011), 473-486.
44. A. Spang, Y. Shiba and P.A. Randazzo, Arf GAPs: Gatekeepers of vesicle generation, FEBS Lett 584 (2010), 2646-2651.
45. C.A. Staton, S.M. Stribbling, S. Tazzyman, R. Hughes, N.J. Brown and C.E. Lewis, Current methods for assaying angiogenesis in vitro and in vivo, Int J Exp Pathol 85 (2004), 233-248.
46. W.R. Stochaj, T. Berkelman, and N. Laird, Preparative Two-Dimensional Gel Electrophoresis with Immobilized pH Gradients, in: Proteins and Proteomics, R.J. Simpson, ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor NY, USA, (2003), pp. 143-218.
47. F. Takada, D.L. Vander Woude, H.Q. Tong, T.G. Thompson, S.C. Watkins, L.M. Kunkel and A.H. Beggs, Myozenin: an alpha-actinin- and gamma-filamin- binding protein of skeletal muscle Z lines, Proc Natl Acad Sci USA 98 (2001), 1595-1600.
48. T. Tammela, G. Zarkada, E. Wallgard, A. Murtomäki, S. Suchting, M. Wirzenius, M. Waltari, M. Hellström, T. Schomber, R. Peltonen, C. Freitas, A. Duarte, H. Isoniemi, P. Laakkonen, G. Christofori, S. Ylä-Herttuala, M. Shibuya, B. Pytowski, A. Eichmann, C. Betsholtz and K. Alitalo, Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation, Nature 454 (2008), 656-660.
49. S. Torii, N. Okamura, Y. Suzuki, T. Ishizawa, K. Yasumoto and K. Sogawa, Cyclic AMP represses the hypoxic induction of hypoxia-inducible factors PC12 cells, J Biochem 146 (2009), 839-844.
50. D. Tse and R.V. Stan, Morphological heterogeneity of endothelium, Semin Thromb Hemost 36 (2010), 236-245.
51. D. Tsuruta and J.C. Jones, The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial subjected to shear stress, J Cell Sci 116 (2003), 4977-4984.
52. S. Wang, Z. Liu, L. Wang and X. Zhang, NF-kappaB signaling pathway, inflammation and colorectal cancer, Cell Mol Immunol 6 (2009), 327-334.
53. R.K. Wierenga, E.G. Kapetaniou and R. Venkatesan, Triosephosphate isomerase: A highly evolved biocatalyst, Cell Mol Life Sci 67 (2010), 3961-3982.
54. C.S. Yang and X. Wang, Green tea and cancer prevention, Nutr Cancer 62 (2010), 931-937.